News for 'Clinical Infectious Diseases'

'Cases will be around for 6 to 9 months'

'Cases will be around for 6 to 9 months'

Rediff.com16 Apr 2020

'The only idea -- the only idea -- of the shutdown was to buy time.'

'We should get our hospitals ready for the second wave'

'We should get our hospitals ready for the second wave'

Rediff.com14 May 2020

'Strengthen hospital capacity, look after patients who need care, primarily ICU care...' 'Train doctors, get PPE, get ventilators, have treatment protocols in place.'

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Rediff.com19 Jul 2021

So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.

Lockdown, early detection reasons for low COVID-19 fatality rate: Govt

Lockdown, early detection reasons for low COVID-19 fatality rate: Govt

Rediff.com26 May 2020

From 3.38 per cent in April, the fatality rate in the country has come down to 2.87 per cent as against 6.4 per cent globally.

US confirms first case of monkeypox

US confirms first case of monkeypox

Rediff.com19 May 2022

'Monkeypox is a rare but potentially serious viral illness that typically begins with flu-like illness and swelling of the lymph nodes and progresses to a rash on the face and body'

BUSTED! 13 myths about hepatitis

BUSTED! 13 myths about hepatitis

Rediff.com28 Jul 2019

Hepatitis B virus is 10 times more infectious than hepatitis C virus and 50-100 times more infectious than HIV.

China: Coronavirus death toll spikes to 425

China: Coronavirus death toll spikes to 425

Rediff.com4 Feb 2020

As the virus continued to spread at an alarming rate, Chinese President Xi Jinping on Monday warned officials of punishment if they shirked responsibility in tackling the virus outbreak.

Expert warns of more virulent coronavirus after milder Omicron

Expert warns of more virulent coronavirus after milder Omicron

Rediff.com7 Jan 2022

The reduced severity of Omicron is good news for now, but it is the result of an "evolutionary mistake" as Covid-19 is transmitting very efficiently and there is no reason for it to become milder, indicating that the next variant could be more virulent, a leading Indian-origin scientist from the University of Cambridge has warned.

'Vaccine Must Go To Older People First'

'Vaccine Must Go To Older People First'

Rediff.com9 Nov 2021

'At the current time, we should be vaccinating all those who are potentially going to get more severe illness, before we start vaccinating very young individuals.'

'It is common for any virus to mutate'

'It is common for any virus to mutate'

Rediff.com22 Dec 2020

'There is no data to show this virus is more deadlier.'

India's first mRNA vaccine gets nod for human trials

India's first mRNA vaccine gets nod for human trials

Rediff.com12 Dec 2020

The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.

Nobel laureate doc warns against relaxing lockdown sans vaccine

Nobel laureate doc warns against relaxing lockdown sans vaccine

Rediff.com30 May 2020

The Australian immunologist, who cautioned that the number of COVID-19 cases will rise in the coming days, said the earliest time frame for an effective vaccine 'going into large numbers of people' is nine to 12 months.

'COVID-19 vaccine will be made in India'

'COVID-19 vaccine will be made in India'

Rediff.com12 Jun 2020

'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'

'It is a sly and tricky virus'

'It is a sly and tricky virus'

Rediff.com23 Mar 2020

'Anyone who takes the eye off the movement of the virus should be prepared for unpleasant surprises.'

Loss of smell, taste added to COVID-19 symptoms: Health min

Loss of smell, taste added to COVID-19 symptoms: Health min

Rediff.com13 Jun 2020

The US's national public health institute, the Centers for Disease Control and Prevention, had in early May incorporated "a new loss of taste or smell" in the list of COVID-19 symptoms.

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Rediff.com12 Nov 2021

The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.

IOC to issue Zika guidance as virus spreads before Rio Olympics

IOC to issue Zika guidance as virus spreads before Rio Olympics

Rediff.com29 Jan 2016

The International Olympic Committee will issue guidelines this week aimed at protecting athletes and visitors from Zika, a mosquito-borne virus spreading rapidly across South America months before the Rio de Janeiro Games in August.

Should Children Get COVID-19 Vaccine?

Should Children Get COVID-19 Vaccine?

Rediff.com8 Sep 2021

Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on children.

647 COVID-19 cases linked to Tablighi event: Centre

647 COVID-19 cases linked to Tablighi event: Centre

Rediff.com4 Apr 2020

Out of the 12 deaths reported in the last 24 hours some are related to the Tablighi Jamaat congregation, Joint Secretary in the Health Ministry Lav Agarwal said in a daily media briefing.

'We don't have a strategy to fight the war'

'We don't have a strategy to fight the war'

Rediff.com24 Mar 2020

'On a daily basis you are saying, you do this, you do that, but where is the blueprint of the war?' 'How many isolations actually we need per hundred thousand people?' 'How many ventilators will we need for 100,000 people?'

When will this pandemic end?

When will this pandemic end?

Rediff.com14 May 2020

'It will take time.' 'It will take time.'

COVID-19: The threat from people with no symptoms

COVID-19: The threat from people with no symptoms

Rediff.com14 May 2020

'Testing is a very good strategy if only symptomatic people are transmitting the disease.' 'Here asymptomatic people, with minimum, trivial symptoms, are transmitting too.' 'Testing, treating, tracing contacts and quarantining them -- yes, it will work up to a certain extent.' 'But more important is physical distancing, hand hygiene, cough etiquette and cocooning, protecting with reverse quarantining the most vulnerable people, senior citizens, people with other major medical problems.' 'To me, that makes much more sense.'

Govt identifies 170 districts in India as COVID-19 hotspots

Govt identifies 170 districts in India as COVID-19 hotspots

Rediff.com15 Apr 2020

The govt said that states have been asked to classify districts which have reported a higher number of cases as hotspots, the districts where cases have been reported as non-hotspots, and green zones where no cases have been reported.

'Covid virus is getting weaker'

'Covid virus is getting weaker'

Rediff.com15 Dec 2020

'If at all there is going to be a second wave, it will not be very strong unlike in the US and Europe.'

COVID-19 doubling rate 11 days, fatality 3.2%: Govt

COVID-19 doubling rate 11 days, fatality 3.2%: Govt

Rediff.com30 Apr 2020

Also, the recovery rate in COVID-19 patients has progressively improved from 13.06 per cent to over 25 per cent in the country over the last 14 days. Addressing a press briefing, Joint Secretary in the ministry Lav Agarwal said the doubling rate of COVID-19 cases in several states is better than the national average.

Fast-spreading Omicron to test Beijing Winter Games bubble

Fast-spreading Omicron to test Beijing Winter Games bubble

Rediff.com3 Jan 2022

Core to the planning is the rigidly-enforced closed loop that physically separates Games-related personnel from the local population

Why India may defeat coronavirus

Why India may defeat coronavirus

Rediff.com12 Apr 2020

'What is hindering us is the fear for the disease.' 'For those below the age of 55 years, it's a mild disease.' 'So take care of yourself, your family and your parents.'

Centre's Omicron FAQ says mutations may lessen vaccine efficacy

Centre's Omicron FAQ says mutations may lessen vaccine efficacy

Rediff.com3 Dec 2021

The Union health ministry on Friday said while there is no evidence to suggest that existing vaccines do not work on the Omicron variant of SARS-CoV-2, some of the mutations reported may decrease the efficacy of the jabs.

Coronavirus may have mutated, potentially evolving: Study

Coronavirus may have mutated, potentially evolving: Study

Rediff.com24 Sep 2020

'Wearing masks, washing our hands, all those things are barriers to transmissibility, or contagion, but as the virus becomes more contagious it statistically is better at getting around those barriers'

India biggest buyer of Covid vaccine with 1.6 bn doses

India biggest buyer of Covid vaccine with 1.6 bn doses

Rediff.com4 Dec 2020

India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the United States company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center.

Experts downplay apprehensions centred around Covid XE

Experts downplay apprehensions centred around Covid XE

Rediff.com7 Apr 2022

Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.

US COVID-19 toll surpasses that of China, higher than 9/11 deaths

US COVID-19 toll surpasses that of China, higher than 9/11 deaths

Rediff.com1 Apr 2020

According to the Johns Hopkins University Coronavirus Resource Centre, more than 4,000 people in the US have died due to COVID-19 and nearly 190,000 have been infected by it.

No food, no medicine and little hope: The many challenges Rohingyas face

No food, no medicine and little hope: The many challenges Rohingyas face

Rediff.com25 Aug 2018

Lives "will once again be at risk" if funding is not urgently secured, United Nations officials have said on the eve of the first anniversary of a military crackdown that forced them to flee their country.

Newton, Darwin take note: Gagandeep Kang makes history

Newton, Darwin take note: Gagandeep Kang makes history

Rediff.com8 May 2019

Women are great team players and collaborators, 'but they don't put themselves forward,' Dr Gagandeep Kang, the first Indian woman scientist to be elected as a Fellow of the Royal Society, tells Veenu Sandhu.

How long before the world gets a COVID-19 vaccine?

How long before the world gets a COVID-19 vaccine?

Rediff.com28 Apr 2020

More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.

COVID-19 vaccine race: Where they stand currently

COVID-19 vaccine race: Where they stand currently

Rediff.com9 Jan 2021

As India prepares to launch its vaccine drive on January 16, here is a look at the options:

Confused about COVID vaccines in India? This is for you

Confused about COVID vaccines in India? This is for you

Rediff.com13 Apr 2021

The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about:

'Omicron may make you more sick'

'Omicron may make you more sick'

Rediff.com29 Nov 2021

'This virus may have more immune evasion capability and therefore, it may make you more sick.'

Please note: Life after vaccine won't be normal

Please note: Life after vaccine won't be normal

Rediff.com20 Dec 2020

'Essentially there are three things the government should be doing: Identify who you are going to get your vaccine from, figure out how you are going to pay for it, and figure out how you're going to deliver it and to whom.'

Beware! New COVID-19 variant with high spike mutations detected in South Africa

Beware! New COVID-19 variant with high spike mutations detected in South Africa

Rediff.com25 Nov 2021

The South African authorities said the detected cases and percentage of people testing positive are both increasing quickly, particularly in particularly in most populated province of Gauteng, North West and Limpopo regions of the country.